Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept

Nadim Rayess, Ehsan Rahimy, Philip Storey, Chirag P. Shah, Jeremy D. Wolfe, Eric Chen, Francis Char Decroos, Sunir J. Garg, Jason Hsu

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint Dive into the research topics of 'Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept'. Together they form a unique fingerprint.

Medicine & Life Sciences